BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15293344)

  • 1. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors.
    Liu Y; Saxena A; Zheng C; Carlsen S; Xiang J
    J Gene Med; 2004 Aug; 6(8):857-68. PubMed ID: 15293344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity.
    Yi H; Guo C; Yu X; Gao P; Qian J; Zuo D; Manjili MH; Fisher PB; Subjeck JR; Wang XY
    Cancer Res; 2011 Nov; 71(21):6611-20. PubMed ID: 21914786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8(+) T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model.
    Bauer C; Sterzik A; Bauernfeind F; Duewell P; Conrad C; Kiefl R; Endres S; Eigler A; Schnurr M; Dauer M
    Cancer Immunol Immunother; 2014 Apr; 63(4):321-33. PubMed ID: 24384835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgene IL-6 enhances DC-stimulated CTL responses by counteracting CD4+25+Foxp3+ regulatory T cell suppression via IL-6-induced Foxp3 downregulation.
    Bhanumathy KK; Zhang B; Ahmed KA; Qureshi M; Xie Y; Tao M; Tan X; Xiang J
    Int J Mol Sci; 2014 Mar; 15(4):5508-21. PubMed ID: 24690994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cells.
    Li HS; Liu C; Xiao Y; Chu F; Liang X; Peng W; Hu J; Neelapu SS; Sun SC; Hwu P; Watowich SS
    Sci Signal; 2016 Sep; 9(447):ra94. PubMed ID: 27678219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells.
    Conroy H; Galvin KC; Higgins SC; Mills KH
    Cancer Immunol Immunother; 2012 Mar; 61(3):425-31. PubMed ID: 22193988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a potent melanoma vaccine capable of stimulating CD8(+) T-cells independently of dendritic cells in a mouse model.
    Powell KL; Stephens AS; Ralph SJ
    Cancer Immunol Immunother; 2015 Jul; 64(7):861-72. PubMed ID: 25893808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosensitization with a Bcl-2 small molecule inhibitor.
    Begley J; Vo DD; Morris LF; Bruhn KW; Prins RM; Mok S; Koya RC; Garban HJ; Comin-Anduix B; Craft N; Ribas A
    Cancer Immunol Immunother; 2009 May; 58(5):699-708. PubMed ID: 18807035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of alpha-galactosylceramide-loaded dendritic cells genetically engineered to express SLC/CCL21 along with tumor antigen against peritoneally disseminated tumor cells.
    Matsuyoshi H; Hirata S; Yoshitake Y; Motomura Y; Fukuma D; Kurisaki A; Nakatsura T; Nishimura Y; Senju S
    Cancer Sci; 2005 Dec; 96(12):889-96. PubMed ID: 16367909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional interleukin-12 gene therapy promotes safe and effective antitumor immunity.
    Komita H; Zhao X; Katakam AK; Kumar P; Kawabe M; Okada H; Braughler JM; Storkus WJ
    Cancer Gene Ther; 2009 Dec; 16(12):883-91. PubMed ID: 19444303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cells.
    Pilon-Thomas S; Verhaegen M; Kuhn L; Riker A; Mulé JJ
    Cancer Immunol Immunother; 2006 Oct; 55(10):1238-46. PubMed ID: 16315029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Stem Cell Vaccination With PD-L1 and CTLA-4 Blockades Enhances the Eradication of Melanoma Stem Cells in a Mouse Tumor Model.
    Zheng F; Dang J; Zhang H; Xu F; Ba D; Zhang B; Cheng F; Chang AE; Wicha MS; Li Q
    J Immunother; 2018 Oct; 41(8):361-368. PubMed ID: 30063587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL3 and CCL20-recruited dendritic cells modified by melanoma antigen gene-1 induce anti-tumor immunity against gastric cancer ex vivo and in vivo.
    He S; Wang L; Wu Y; Li D; Zhang Y
    J Exp Clin Cancer Res; 2010 Apr; 29(1):37. PubMed ID: 20420712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antitumor immune response mediated by paclitaxel-conjugated nanohybrid oncolytic adenovirus with dendritic cell therapy.
    Kim IW; Yoon AR; Hong J; Kasala D; Yun CO
    Front Immunol; 2024; 15():1355566. PubMed ID: 38835775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccine.
    Lapenta C; Donati S; Spadaro F; Lattanzi L; Urbani F; Macchia I; Sestili P; Spada M; Cox MC; Belardelli F; Santini SM
    Cancer Immunol Immunother; 2019 Nov; 68(11):1791-1804. PubMed ID: 31620858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models.
    Tada T; Norton TD; Leibowitz R; Landau NR
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38658032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant-free peptide vaccine targeting Clec9a on dendritic cells can induce robust antitumor immune response through Syk/IL-21 axis.
    Gou S; Wang S; Liu W; Chen G; Zhang D; Du J; Yan Z; Wang H; Zhai W; Sui X; Wu Y; Qi Y; Gao Y
    Theranostics; 2021; 11(15):7308-7321. PubMed ID: 34158852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of anti-tumor immunity specific to murine glioma by vaccination with tumor cell lysate-pulsed dendritic cells engineered to produce interleukin-12.
    Kim CH; Hong MJ; Park SD; Kim CK; Park MY; Sohn HJ; Cho HI; Kim TG; Hong YK
    Cancer Immunol Immunother; 2006 Nov; 55(11):1309-19. PubMed ID: 16463038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD27 Antibody Potentiates Antitumor Effect of Dendritic Cell-Based Vaccine in Prostate Cancer-Bearing Mice.
    Wei SM; Fei JX; Tao F; Pan HL; Shen Q; Wang L; Wu YJ; Zhou L; Zhu SX; Liao WB; Ji H; Xin ZL
    Int Surg; 2015 Jan; 100(1):155-63. PubMed ID: 25594656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-loaded Monocyte Administration and Flt3 Ligand Augment the Antitumor Efficacy of Immune Checkpoint Blockade in a Murine Melanoma Model.
    D'Anniballe VM; Huang MN; Lueck BD; Nicholson LT; McFatridge I; Gunn MD
    J Immunother; 2023 Nov-Dec 01; 46(9):333-340. PubMed ID: 37737688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.